Welcome to our dedicated page for Aveanna Healthcare Holdings SEC filings (Ticker: AVAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aveanna Healthcare Holdings Inc. filings document the public-company disclosures of a home healthcare operator with pediatric and adult care services. Its 8-K reports cover operating and financial results, guidance updates, Regulation FD investor presentations, material-event disclosures, capital-structure matters, and material agreements tied to the company and its common stock.
Proxy and governance filings describe annual meeting matters, board composition, committee service, executive compensation arrangements, employment agreements, stock incentive plan matters, and stockholders agreement provisions, including transfer restrictions and ownership-guideline-related terms. The filing record also includes director transitions and governance disclosures connected to compensation, nominating and corporate governance, and clinical quality and compliance oversight.
JHW ILIAD HOLDINGS, LLC notified of a proposed sale of common stock in AVEANA HEALTHCARE HOLDINGS INC. The notice shows 1,047,913 shares associated with a 06/03/2026 entry and a monetary figure of $6,538,977.00 in the excerpt. The sale is reported via RBC Capital Markets LLC.
Aveanna Healthcare Holdings Inc. reported a Form 144 notice for the proposed sale of 5,842,240 shares by J.H. Whitney VII, L.P. on or about 06/24/2026. The filing lists an aggregate value of $36,455,577.00 associated with the transaction and references the securities originally issued in a private placement dated 03/24/2020.
Aveanna Healthcare Holdings insider update: Investment entities associated with Paul R. Vigano, a ten percent owner, reported open-market sales of an aggregate 7,000,000 shares of Aveanna common stock on June 3, 2026 at $6.24 per share.
The sales were made indirectly through J.H. Whitney VII, L.P., JHW Iliad Holdings LLC and JHW Iliad Holdings II LLC. After these transactions, J.H. Whitney VII, L.P. held 13,450,547 shares, JHW Iliad Holdings LLC held 2,412,602 shares and JHW Iliad Holdings II LLC held 252,899 shares. Additional indirect holdings remained at PSA Iliad Holdings LLC with 1,426,034 shares and PSA Healthcare Investment Holdings LLC with 15,523,810 shares, while Vigano reported no Aveanna shares held directly.
Aveanna Healthcare Holdings, Inc. insider filing shows investment entities associated with Robert M. Williams Jr. executed open-market sales of a combined 7,000,000 shares of common stock at $6.24 per share on June 3, 2026. These sales were made indirectly through J.H. Whitney–affiliated entities, not by Williams personally, and he disclaims beneficial ownership beyond his pecuniary interest. After the transactions, indirect holdings reported include 13,450,547 shares held by J.H. Whitney VII, L.P., 2,412,602 shares held by JHW Iliad Holdings LLC, and 252,899 shares held by JHW Iliad Holdings II LLC, alongside other indirect positions.
J.H. Whitney Equity Partners VII, LLC, a ten percent owner of Aveanna Healthcare Holdings, Inc., reported that an affiliated entity, J.H. Whitney VII, L.P., completed an open-market sale of 5,842,240 shares of common stock at $6.24 per share. After this sale, J.H. Whitney VII, L.P. continues to hold 13,450,547 shares indirectly. Related entities PSA Healthcare Investment Holdings LLC and PSA Iliad Holdings LLC hold 15,523,810 and 1,426,034 shares, respectively, while direct holdings by the reporting person are shown as zero. The reporting entities disclaim beneficial ownership beyond their pecuniary interest.
Aveanna Healthcare Holdings Inc. has completed its acquisition of Family First Homecare, a multi-state pediatric home care provider with 27 locations across seven states. The company paid a cash purchase price of $175.5 million, funded entirely with cash on hand, to acquire all membership interests of Family First Holding, LLC.
Following this deal, Aveanna updated its full fiscal year 2026 outlook to reflect Family First’s contribution. Revenue guidance increased to $2.63–$2.65 billion, up from $2.56–$2.58 billion, driven by Family First’s revenue guidance of $70.0 million. Adjusted EBITDA guidance rose to $338–$342 million, from $328–$332 million, reflecting Family First’s Adjusted EBITDA guidance of $10.0 million.
Aveanna Healthcare Holdings Inc. reported the results of its 2026 Annual Meeting of Stockholders held on May 29, 2026. Stockholders elected three Class II directors—Rodney D. Windley, Sam Weil, and Steven E. Rodgers—to three-year terms ending at the 2029 Annual Meeting.
Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending January 2, 2027, with 198,808,170 votes for and 477,379 against. Stockholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 160,094,458 votes for and 19,490,871 against. No other matters were considered.